For research use only. Not for therapeutic Use.
RAD51-IN-3 is a Rad51 inhibitor extracted from patent WO2019051465A1, compound Example 66A[1].
| Catalog Number | I014888 |
| CAS Number | 2301084-99-9 |
| Synonyms | propan-2-yl N-[4-[5-[4-(benzylcarbamoylamino)-2-(tert-butylsulfamoyl)phenyl]-1,3-thiazol-2-yl]cyclohexyl]carbamate |
| Molecular Formula | C31H41N5O5S2 |
| Purity | ≥95% |
| InChI | InChI=1S/C31H41N5O5S2/c1-20(2)41-30(38)35-23-13-11-22(12-14-23)28-32-19-26(42-28)25-16-15-24(17-27(25)43(39,40)36-31(3,4)5)34-29(37)33-18-21-9-7-6-8-10-21/h6-10,15-17,19-20,22-23,36H,11-14,18H2,1-5H3,(H,35,38)(H2,33,34,37) |
| InChIKey | LWGKIZXUYDQPJG-UHFFFAOYSA-N |
| SMILES | CC(C)OC(=O)NC1CCC(CC1)C2=NC=C(S2)C3=C(C=C(C=C3)NC(=O)NCC4=CC=CC=C4)S(=O)(=O)NC(C)(C)C |
| Reference | [1]. Alfredo C. Castro, et al. Rad51 inhibitors. WO2019051465A1. |
